NanoCarrier Co., Ltd. (4571.T)
JPY 150.0
(-1.96%)
JPY 150.0
(-1.96%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 5.07 Billion JPY | -12.33% |
| 2022 | 5.78 Billion JPY | -18.94% |
| 2021 | 7.13 Billion JPY | -8.75% |
| 2020 | 7.82 Billion JPY | -12.56% |
| 2019 | 8.94 Billion JPY | 4.39% |
| 2018 | 8.56 Billion JPY | 12.34% |
| 2017 | 7.62 Billion JPY | -41.06% |
| 2016 | 12.93 Billion JPY | -15.9% |
| 2015 | 15.38 Billion JPY | 4.64% |
| 2014 | 14.7 Billion JPY | 2.53% |
| 2013 | 14.34 Billion JPY | 155.8% |
| 2012 | 5.6 Billion JPY | 53.06% |
| 2011 | 3.66 Billion JPY | 79.73% |
| 2010 | 2.03 Billion JPY | 79.49% |
| 2009 | 1.13 Billion JPY | -25.76% |
| 2008 | 1.52 Billion JPY | -25.19% |
| 2007 | 2.04 Billion JPY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 4.89 Billion JPY | -3.46% |
| 2023 Q3 | 5.16 Billion JPY | -4.97% |
| 2023 FY | 5.07 Billion JPY | -12.33% |
| 2023 Q4 | 5.07 Billion JPY | -1.89% |
| 2023 Q1 | 5.65 Billion JPY | -2.28% |
| 2023 Q2 | 5.43 Billion JPY | -3.78% |
| 2022 Q4 | 5.78 Billion JPY | -3.0% |
| 2022 Q3 | 5.96 Billion JPY | -6.06% |
| 2022 FY | 5.78 Billion JPY | -18.94% |
| 2022 Q1 | 6.51 Billion JPY | -8.64% |
| 2022 Q2 | 6.34 Billion JPY | -2.63% |
| 2021 Q2 | 8.19 Billion JPY | -5.06% |
| 2021 Q4 | 7.13 Billion JPY | -6.52% |
| 2021 FY | 7.13 Billion JPY | -8.75% |
| 2021 Q1 | 8.63 Billion JPY | 10.4% |
| 2021 Q3 | 7.63 Billion JPY | -6.87% |
| 2020 FY | 7.82 Billion JPY | -12.56% |
| 2020 Q1 | 8.92 Billion JPY | -0.23% |
| 2020 Q2 | 8.66 Billion JPY | -2.94% |
| 2020 Q3 | 8.12 Billion JPY | -6.22% |
| 2020 Q4 | 7.82 Billion JPY | -3.72% |
| 2019 Q1 | 8.19 Billion JPY | -4.37% |
| 2019 Q3 | 9.64 Billion JPY | 0.66% |
| 2019 Q4 | 8.94 Billion JPY | -7.26% |
| 2019 FY | 8.94 Billion JPY | 4.39% |
| 2019 Q2 | 9.58 Billion JPY | 16.94% |
| 2018 Q1 | 8.41 Billion JPY | 10.29% |
| 2018 Q3 | 7.6 Billion JPY | -12.08% |
| 2018 Q4 | 8.56 Billion JPY | 12.72% |
| 2018 FY | 8.56 Billion JPY | 12.34% |
| 2018 Q2 | 8.64 Billion JPY | 2.77% |
| 2017 Q2 | 10.96 Billion JPY | -8.99% |
| 2017 Q4 | 7.62 Billion JPY | -10.85% |
| 2017 FY | 7.62 Billion JPY | -41.06% |
| 2017 Q1 | 12.05 Billion JPY | -6.86% |
| 2017 Q3 | 8.55 Billion JPY | -22.01% |
| 2016 Q3 | 13.78 Billion JPY | 0.21% |
| 2016 FY | 12.93 Billion JPY | -15.9% |
| 2016 Q1 | 14.42 Billion JPY | -6.22% |
| 2016 Q4 | 12.93 Billion JPY | -6.12% |
| 2016 Q2 | 13.75 Billion JPY | -4.68% |
| 2015 Q2 | 13.84 Billion JPY | -4.22% |
| 2015 Q1 | 14.45 Billion JPY | -1.72% |
| 2015 FY | 15.38 Billion JPY | 4.64% |
| 2015 Q3 | 17.21 Billion JPY | 24.36% |
| 2015 Q4 | 15.38 Billion JPY | -10.61% |
| 2014 Q4 | 14.7 Billion JPY | 2.26% |
| 2014 Q3 | 14.37 Billion JPY | 1.47% |
| 2014 FY | 14.7 Billion JPY | 2.53% |
| 2014 Q1 | 13.98 Billion JPY | -2.51% |
| 2014 Q2 | 14.17 Billion JPY | 1.36% |
| 2013 Q1 | 5.63 Billion JPY | 0.43% |
| 2013 FY | 14.34 Billion JPY | 155.8% |
| 2013 Q2 | 5.77 Billion JPY | 2.59% |
| 2013 Q3 | 14.92 Billion JPY | 158.37% |
| 2013 Q4 | 14.34 Billion JPY | -3.91% |
| 2012 FY | 5.6 Billion JPY | 53.06% |
| 2012 Q1 | 3.52 Billion JPY | -3.62% |
| 2012 Q2 | 3.47 Billion JPY | -1.48% |
| 2012 Q3 | 5.19 Billion JPY | 49.29% |
| 2012 Q4 | 5.6 Billion JPY | 7.99% |
| 2011 Q4 | 3.66 Billion JPY | 82.16% |
| 2011 Q3 | 2.01 Billion JPY | 3.56% |
| 2011 Q1 | 1.9 Billion JPY | -6.31% |
| 2011 FY | 3.66 Billion JPY | 79.73% |
| 2011 Q2 | 1.94 Billion JPY | 1.69% |
| 2010 Q2 | 941.21 Million JPY | -12.14% |
| 2010 Q3 | 1.49 Billion JPY | 58.51% |
| 2010 Q4 | 2.03 Billion JPY | 36.59% |
| 2010 Q1 | 1.07 Billion JPY | -5.64% |
| 2010 FY | 2.03 Billion JPY | 79.49% |
| 2009 FY | 1.13 Billion JPY | -25.76% |
| 2009 Q3 | 1.24 Billion JPY | 0.0% |
| 2009 Q4 | 1.13 Billion JPY | -8.64% |
| 2008 Q3 | 1.63 Billion JPY | 0.0% |
| 2008 FY | 1.52 Billion JPY | -25.19% |
| 2008 Q4 | 1.52 Billion JPY | -6.39% |
| 2007 FY | 2.04 Billion JPY | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 6.58 Billion JPY | 23.038% |
| PRISM BioLab Co.,LTD | 1.21 Billion JPY | -318.621% |
| GNI Group Ltd. | 62.39 Billion JPY | 91.872% |
| Linical Co., Ltd. | 18.53 Billion JPY | 72.647% |
| Trans Genic Inc. | 9.81 Billion JPY | 48.31% |
| MEDINET Co., Ltd. | 5.63 Billion JPY | 9.99% |
| Soiken Holdings Inc. | 6.94 Billion JPY | 26.991% |
| Cytori Cell Research Institute, Inc. | 5.81 Billion JPY | 12.81% |
| AnGes, Inc. | 28.89 Billion JPY | 82.448% |
| OncoTherapy Science, Inc. | 867.27 Million JPY | -484.737% |
| Nxera Pharma Co., Ltd. | 157.19 Billion JPY | 96.774% |
| Immuno-Biological Laboratories Co., Ltd. | 1.61 Billion JPY | -213.316% |
| Carna Biosciences, Inc. | 4.34 Billion JPY | -16.584% |
| CanBas Co., Ltd. | 2.43 Billion JPY | -108.45% |
| D. Western Therapeutics Institute, Inc. | 2.37 Billion JPY | -113.674% |
| RaQualia Pharma Inc. | 6.93 Billion JPY | 26.824% |
| Chiome Bioscience Inc. | 1.75 Billion JPY | -189.547% |
| Kidswell Bio Corporation | 5.08 Billion JPY | 0.281% |
| PeptiDream Inc. | 67.12 Billion JPY | 92.445% |
| Oncolys BioPharma Inc. | 2.04 Billion JPY | -148.519% |
| Ribomic Inc. | 3.54 Billion JPY | -42.963% |
| SanBio Company Limited | 5.04 Billion JPY | -0.475% |
| Healios K.K. | 15.15 Billion JPY | 66.537% |
| BrightPath Biotherapeutics Co., Ltd. | 1.23 Billion JPY | -312.213% |
| Kubota Pharmaceutical Holdings Co., Ltd. | 3.01 Billion JPY | -68.146% |
| Delta-Fly Pharma, Inc. | 1.47 Billion JPY | -244.013% |
| StemRIM | 9.08 Billion JPY | 44.149% |
| CellSource Co., Ltd. | 6.87 Billion JPY | 26.287% |
| FunPep Company Limited | 2.49 Billion JPY | -103.573% |
| Kringle Pharma, Inc. | 2.61 Billion JPY | -93.66% |
| Stella Pharma Corporation | 3.82 Billion JPY | -32.734% |
| TMS Co., Ltd. | 3.55 Billion JPY | -42.662% |
| Noile-Immune Biotech Inc. | 5.77 Billion JPY | 12.246% |
| Cuorips Inc. | 6.18 Billion JPY | 18.003% |
| K Pharma,Inc. | 3.31 Billion JPY | -53.03% |
| Takara Bio Inc. | 123.2 Billion JPY | 95.884% |
| ReproCELL Incorporated | 9.05 Billion JPY | 43.98% |
| PhoenixBio Co., Ltd. | 2.71 Billion JPY | -86.765% |
| StemCell Institute Inc. | 6.54 Billion JPY | 22.494% |
| Japan Tissue Engineering Co., Ltd. | 6.98 Billion JPY | 27.437% |
| CellSeed Inc. | 2.46 Billion JPY | -105.667% |